Lon­don list­ed PureTech Health joins forces with ninth big phar­ma part­ner — Boehringer In­gel­heim

PureTech Health — which is de­vel­op­ing ther­a­peu­tics to tack­le dys­func­tions in the brain-im­mune-gut ax­is — is adding an­oth­er big bio­phar­ma­ceu­ti­cal com­pa­ny, Ger­many’s Boehringer In­gel­heim, to its rich …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER